GlassScriptPhysician profile
Leslie MD Skinner
NPI 1174799704
$1,597.70
in general payments reported to CMS, 2019-2025
22 companies · $205 in 2025
The $205 reported for 2025 was more than what 75% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $298 · 2020: $35.82 · 2021: $230 · 2022: $189 · 2023: $387 · 2024: $253 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $845.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $845.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $226.96 | 2019-2025 | |
| Corium, LLC | $198.78 | 2021-2025 | Azstarys |
| Biogen, INC. | $142.82 | 2019-2023 | Spinraza |
| Genzyme Corporation | $125.00 | 2023 | |
| Sanofi Pasteur INC. | $119.49 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $112.89 | 2024-2025 | |
| Supernus Pharmaceuticals, INC. | $106.16 | 2021-2023 | Qelbree |
| Merck Sharp & Dohme LLC | $92.69 | 2019-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Seqirus USA INC | $85.79 | 2021-2025 | Flucelvax, Flucelvax Quadrivalent |
| Tris Pharma INC | $80.16 | 2019-2022 | |
| Genentech USA, INC. | $64.33 | 2024 | Xolair |
| Kaleo, INC. | $39.13 | 2021-2022 | |
| Ultragenyx Pharmaceutical INC. | $27.61 | 2023 | |
| Ironshore Pharmaceuticals INC. | $27.60 | 2019-2024 | |
| Biofire Diagnostics, LLC | $25.00 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $24.81 | 2019-2021 | |
| Acadia Pharmaceuticals INC | $19.96 | 2023 | Daybue |
| Biomarin Pharmaceutical INC. | $18.38 | 2024 | Voxzogo 1.2mg |
| Sobi, INC | $17.88 | 2021 | |
| Neos Therapeutics, LP | $14.58 | 2022 | |
| Shire North American Group INC | $14.37 | 2019 | |
| Adlon Therapeutics L.P. | $13.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leslie Skinner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.